Table 7. Overview of the synthesised findings: Characteristics of individuals.
| Construct: | Sub-themes: | Quotes: |
|---|---|---|
| Knowledge & beliefs about the intervention | Positive beliefs about risk stratification | “The majority of HCPs agreed that risk stratification for ovarian cancer would help identify those in most need of screening (89.8%, N = 131). 63.7% (N = 93) felt it would give patients a sense of control over their health. 71.9% (N = 105) of HCPs felt patients would be reassured by being stratified into a low-risk group.” [30] |
| Negative beliefs about risk stratification | “45.2% (N = 66) of HCPs felt being stratified into a low-risk group would give patients a false sense of security. 43.1% (N = 63) of HCPs felt that being stratified into a high-risk group would have a negative impact on wellbeing. 34.4% (N = 50) of HCPs felt that being stratified into an intermediate-risk group would have a negative impact on wellbeing.” [30] | |
| Self-efficacy | “88.3% of HCPs reported that they would be probably or definitely willing to discuss stratified interventions for patients at low risk of ovarian cancer. 85.0% of HCPs reported that they would be probably or definitely willing to discuss stratified interventions for patients at intermediate risk of ovarian cancer. 82.2% of HCPs reported that they would be probably or definitely willing to discuss stratified interventions for patients at high risk of ovarian cancer.” [30] |
|
| Individual stage of change | “All respondents (15 out of 15) talked about the usefulness of a clinical questionnaire to assess BC risk and determine the need for further evaluations or genetic testing. This appears to be well integrated into their practice, but the collection of risk factors, notably family history, varies across settings, specialties, and HPs.” [35] | |
| Other personal attributes | “… the government does not pay for mutation on PALB2 because it is not considered as a high-risk gene. So, there are at-risk women for whom we do nothing. And for me, this is a problem because it is recognized as a BC risk and there are available interventions. But who decides when the risk is sufficiently high to do something?!” [35] |
BC–breast cancer
HCP–healthcare professional/provider
HP–health professional
Mammography screening 2.0—individualised mammography screening
PCP–primary care provider/practitioner
Quotes in italics represent those from HCPs. Quotes that are not in italics represent those of the author.
HCPs roles have been included where available in the original paper.